Status:
COMPLETED
Ocular Blood Flow in Glaucoma Patients - the Leuven Eye Study
Lead Sponsor:
Universitaire Ziekenhuizen KU Leuven
Conditions:
Open Angle Glaucoma
Normal Tension Glaucoma
Eligibility:
All Genders
18+ years
Brief Summary
Glaucoma is a leading cause of blindness worldwide, whose treatment - intraocular pressure lowering - is only partially effective in preventing disease progression. Accordingly, other variables, such ...
Detailed Description
1. Demographic and clinical ophthalmology-related examination data will be collected, including intraocular pressure measurement using dynamic contour tonometry 2. Visual field testing will be perform...
Eligibility Criteria
Inclusion
- individuals over 18 years old
- willing to sign an informed consent and able to comply with the requirements of the study
- having no other ocular diseases besides glaucoma
Exclusion
- history of ocular trauma
- intraocular surgery (except for cataract surgery)
- eye disease (except glaucoma)
- systemic diseases with ocular involvement like diabetes
Key Trial Info
Start Date :
February 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2014
Estimated Enrollment :
770 Patients enrolled
Trial Details
Trial ID
NCT01840202
Start Date
February 1 2013
End Date
December 1 2014
Last Update
May 29 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UZ Leuven
Leuven, Vlaams-Brabant, Belgium, 3000 Leuven